Vietnam Recalls Novalac Allernova AR Infant Formula Due to Health Risks
The Vietnam Food Safety Authority has issued an urgent recall warning for Allernova AR infant formula, produced by Laboratoires Novalac, following reports of gastrointestinal side effects in infants. The recall specifically targets production batch number 183403, which has been linked to 12 documented cases of illness, including vomiting and diarrhea.
Why the Allernova AR Recall Was Issued
The decision to recall the product follows a coordinated monitoring effort by health officials. According to authorities, the Anses nutritional monitoring system and the SignalConso platform identified 12 infants suffering from gastrointestinal issues after consuming the formula. One of these infants required hospitalization after a stool sample tested positive for adenovirus, a common cause of gastroenteritis.
Officials have confirmed that this situation is unrelated to recent international warnings regarding cereulide toxins in other infant formulas. While adenovirus is generally not transmitted through breast milk, the investigation into this specific batch remains a priority for food safety agencies to protect infant health.
The recall is specifically limited to production batch number 183403 manufactured by Laboratoires Novalac, and authorities have explicitly stated this event is unconnected to separate international alerts concerning cereulide toxins in baby formula.
Regulatory Actions and Next Steps
The Food Safety Authority has mandated that provincial and city health departments review the registration and self-declaration status of Allernova AR products. Local agencies are currently tasked with identifying the total quantities of the affected batch—including import, sales, and remaining inventory—to determine appropriate disposal measures.
In a move to prevent further exposure, the Food Safety Authority has contacted the E-commerce and Digital Economy Department under the Ministry of Industry and Trade. This request seeks to ensure that online platforms and website operators immediately stop the sale of the affected formula and remove all related product listings. Retailers and distributors are expected to cooperate fully with these directives to ensure the product is pulled from the market.
Samantha Carter notes that the rapid move to coordinate with e-commerce platforms highlights the evolving challenge of managing recalls in a digital-first marketplace. By targeting both physical distribution chains and online storefronts simultaneously, regulators are attempting to close the gap between initial safety signals and consumer access to potentially harmful goods.
Frequently Asked Questions
Which specific product and batch is affected by this recall?
The recall applies exclusively to Allernova AR infant formula, produced by Laboratoires Novalac, with production batch number 183403.
What symptoms have been reported in connection with this formula?
Infants consuming the affected batch have reported gastrointestinal side effects, specifically vomiting and diarrhea. One infant was hospitalized following an adenovirus diagnosis.
What should I do if I have this product?
Consumers are advised to stop using the product immediately. Relevant authorities are working with distributors to manage the recall and provide further guidance on disposal.
Have you checked your pantry for the specific batch number mentioned in this safety alert?